Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michele Milella, MD"'
Autor:
Marco Sposito, MD, Ilaria Mariangela Scaglione, MD, Serena Eccher, MD, Luca Pasqualin, MD, Alice Avancini, PhD, Chiara Colato, MD, Paolo Rosina, MD, Michele Simbolo, PhD, Anna Caliò, MD, PhD, Aldo Scarpa, MD, Michele Milella, MD, Sara Pilotto, MD, PhD, Lorenzo Belluomini, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100597- (2023)
Background: Enteric-type adenocarcinoma of the lung (lung-ETAC) is a rare form of lung cancer with histologic similarities to colorectal cancer, with aggressive behavior and unfavorable prognosis. Case Presentation: An 81-year-old man presented with
Externí odkaz:
https://doaj.org/article/af05460e775d4d998a2c1a08c4afd08d
Autor:
Sartori G; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Belluomini L; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Trovato R; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Minari R; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Caliò A; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Ugel S; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Milella M; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Pilotto S; Giulia Sartori, MD and Lorenzo Belluomini, MD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Rosalinda Trovato, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; Roberta Minari, PhD, Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Anna Caliò, MD, PhD, Section of Pathology, Department of Diagnostic and Public Health, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy; Stefano Ugel, PhD, Immunology Section, Department of Medicine, Verona University Hospital, Verona, Italy; and Michele Milella, MD, PhD and Sara Pilotto, MD, PhD, Section of Oncology, Department of Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2020 Nov; Vol. 4, pp. 1049-1051.